Controversies in Neuro-Oncology (Avastin and Malignant Gliomas)

Controversies in Neuro-Oncology (Avastin and Malignant Gliomas)

by Thomas C. Chen, Marc Chamberlain

195 pages· 2010· ISBN 9781608051328
About
Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This ebook presents a detailed account on the use of avastin in treating cancer patients. a discussion on clinical experiences and the controversial debate among researchers of avastin's role in restricting malignant gliomas is also included giving readers a diverse perspective on the rationale of treating CNS tumors.

Discuss Controversies in Neuro-Oncology (Avastin and Malignant Gliomas) with other readers

Join or start a book club for Controversies in Neuro-Oncology (Avastin and Malignant Gliomas) on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.

Frequently asked questions

How do I join a book club for Controversies in Neuro-Oncology (Avastin and Malignant Gliomas)?

Sign up free on Readfeed, then browse public clubs or start your own club with Controversies in Neuro-Oncology (Avastin and Malignant Gliomas) as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.

Can I discuss Controversies in Neuro-Oncology (Avastin and Malignant Gliomas) with other readers online?

Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Controversies in Neuro-Oncology (Avastin and Malignant Gliomas) with readers worldwide — whether your club is virtual, in-person, or hybrid.

Is Readfeed free?

Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.